Michael Thomas Osborne, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fluorodeoxyglucose F18 | 19 | 2023 | 2017 | 2.600 |
Why?
|
Noise, Transportation | 4 | 2023 | 50 | 2.510 |
Why?
|
Myocardial Perfusion Imaging | 4 | 2023 | 555 | 1.830 |
Why?
|
Coronary Vasospasm | 2 | 2023 | 88 | 1.760 |
Why?
|
Sarcoidosis | 8 | 2019 | 505 | 1.630 |
Why?
|
Coronary Artery Disease | 14 | 2023 | 6489 | 1.580 |
Why?
|
Positron-Emission Tomography | 24 | 2023 | 6274 | 1.450 |
Why?
|
Arteritis | 4 | 2024 | 159 | 1.280 |
Why?
|
Heart | 9 | 2024 | 4465 | 0.910 |
Why?
|
Cardiovascular Diseases | 12 | 2024 | 15161 | 0.860 |
Why?
|
Plaque, Atherosclerotic | 6 | 2023 | 1519 | 0.850 |
Why?
|
Superior Vena Cava Syndrome | 1 | 2022 | 54 | 0.830 |
Why?
|
Takayasu Arteritis | 1 | 2023 | 96 | 0.800 |
Why?
|
Coronary Circulation | 5 | 2021 | 1573 | 0.760 |
Why?
|
Amygdala | 6 | 2023 | 1315 | 0.740 |
Why?
|
Intra-Abdominal Fat | 2 | 2021 | 591 | 0.660 |
Why?
|
Giant Cell Arteritis | 1 | 2023 | 292 | 0.660 |
Why?
|
Cardiomyopathies | 8 | 2018 | 1913 | 0.660 |
Why?
|
Bioprosthesis | 1 | 2022 | 596 | 0.610 |
Why?
|
Cardiovascular System | 2 | 2024 | 832 | 0.580 |
Why?
|
Microcirculation | 2 | 2018 | 1286 | 0.560 |
Why?
|
Radiopharmaceuticals | 10 | 2023 | 2662 | 0.540 |
Why?
|
Myocardium | 4 | 2023 | 4776 | 0.530 |
Why?
|
Sodium Fluoride | 3 | 2021 | 65 | 0.520 |
Why?
|
Fluorine Radioisotopes | 4 | 2022 | 449 | 0.500 |
Why?
|
Aorta, Thoracic | 1 | 2021 | 1082 | 0.490 |
Why?
|
Cardiac Imaging Techniques | 1 | 2016 | 269 | 0.460 |
Why?
|
Diet, Carbohydrate-Restricted | 1 | 2016 | 262 | 0.450 |
Why?
|
Heart Valve Prosthesis | 1 | 2022 | 1488 | 0.450 |
Why?
|
Environmental Pollutants | 1 | 2022 | 1180 | 0.440 |
Why?
|
Pyrazoles | 1 | 2023 | 1973 | 0.440 |
Why?
|
Stress, Physiological | 1 | 2020 | 1404 | 0.440 |
Why?
|
Stress, Psychological | 4 | 2020 | 4245 | 0.440 |
Why?
|
Calcinosis | 1 | 2021 | 1499 | 0.410 |
Why?
|
Heart Diseases | 2 | 2021 | 2790 | 0.390 |
Why?
|
Air Pollutants | 2 | 2022 | 2817 | 0.390 |
Why?
|
Glucose | 2 | 2023 | 4396 | 0.390 |
Why?
|
Inflammation | 11 | 2024 | 10634 | 0.360 |
Why?
|
Purines | 2 | 2023 | 594 | 0.360 |
Why?
|
Fasting | 1 | 2016 | 1591 | 0.360 |
Why?
|
Predictive Value of Tests | 10 | 2023 | 15070 | 0.350 |
Why?
|
Adiposity | 2 | 2019 | 1807 | 0.350 |
Why?
|
Myocarditis | 1 | 2016 | 771 | 0.330 |
Why?
|
Thrombosis | 1 | 2022 | 2968 | 0.320 |
Why?
|
Humans | 64 | 2024 | 744220 | 0.300 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2013 | 964 | 0.280 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2021 | 11732 | 0.270 |
Why?
|
Coronary Vessels | 3 | 2023 | 3107 | 0.260 |
Why?
|
Image Enhancement | 1 | 2016 | 2921 | 0.260 |
Why?
|
Molecular Imaging | 3 | 2022 | 831 | 0.250 |
Why?
|
Heart Failure | 4 | 2023 | 10905 | 0.250 |
Why?
|
Nuclear Medicine | 1 | 2017 | 233 | 0.240 |
Why?
|
Heart Transplantation | 2 | 2018 | 3123 | 0.240 |
Why?
|
Atrial Fibrillation | 1 | 2022 | 5034 | 0.230 |
Why?
|
Social Class | 3 | 2022 | 1999 | 0.220 |
Why?
|
3-Hydroxybutyric Acid | 1 | 2023 | 87 | 0.220 |
Why?
|
Stroke | 2 | 2022 | 9981 | 0.210 |
Why?
|
Receptors, Somatostatin | 1 | 2023 | 129 | 0.210 |
Why?
|
Vena Cava, Superior | 1 | 2022 | 193 | 0.200 |
Why?
|
Coronary Angiography | 6 | 2023 | 4578 | 0.190 |
Why?
|
Bone Marrow | 3 | 2021 | 2944 | 0.190 |
Why?
|
Myocardial Ischemia | 2 | 2023 | 2148 | 0.190 |
Why?
|
Risk Factors | 16 | 2023 | 72280 | 0.180 |
Why?
|
Neurobiology | 1 | 2021 | 121 | 0.180 |
Why?
|
Heart Murmurs | 1 | 2020 | 94 | 0.180 |
Why?
|
Sarcoma, Myeloid | 1 | 2020 | 59 | 0.170 |
Why?
|
Atherosclerosis | 3 | 2021 | 3444 | 0.170 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2021 | 125 | 0.170 |
Why?
|
Radionuclide Imaging | 1 | 2023 | 2030 | 0.160 |
Why?
|
Fluorides | 1 | 2019 | 127 | 0.160 |
Why?
|
Ventricular Function, Left | 4 | 2023 | 3669 | 0.160 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2023 | 1107 | 0.160 |
Why?
|
Fractional Flow Reserve, Myocardial | 2 | 2018 | 290 | 0.150 |
Why?
|
Arteries | 2 | 2019 | 1119 | 0.150 |
Why?
|
Heart Failure, Diastolic | 1 | 2018 | 69 | 0.150 |
Why?
|
Brain | 2 | 2023 | 26413 | 0.150 |
Why?
|
Rubidium Radioisotopes | 2 | 2013 | 85 | 0.140 |
Why?
|
Tomography, X-Ray Computed | 4 | 2021 | 20123 | 0.140 |
Why?
|
Prosthesis Failure | 1 | 2022 | 1206 | 0.140 |
Why?
|
Prognosis | 8 | 2023 | 29050 | 0.140 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2017 | 153 | 0.140 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2020 | 336 | 0.140 |
Why?
|
Heart Neoplasms | 1 | 2020 | 374 | 0.140 |
Why?
|
Arthritis, Rheumatoid | 2 | 2024 | 3712 | 0.140 |
Why?
|
Heart Atria | 1 | 2022 | 1356 | 0.130 |
Why?
|
Obesity, Abdominal | 1 | 2019 | 361 | 0.130 |
Why?
|
Middle Aged | 24 | 2023 | 213367 | 0.130 |
Why?
|
Periodontal Diseases | 1 | 2019 | 449 | 0.130 |
Why?
|
Environmental Exposure | 4 | 2023 | 4236 | 0.130 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2022 | 3256 | 0.130 |
Why?
|
Hematopoiesis | 3 | 2019 | 2069 | 0.130 |
Why?
|
Diastole | 1 | 2018 | 791 | 0.130 |
Why?
|
Retrospective Studies | 12 | 2023 | 77426 | 0.130 |
Why?
|
Erectile Dysfunction | 1 | 2019 | 460 | 0.130 |
Why?
|
Coronary Stenosis | 1 | 2021 | 834 | 0.120 |
Why?
|
Breast Neoplasms | 1 | 2021 | 20817 | 0.120 |
Why?
|
Longitudinal Studies | 4 | 2020 | 13990 | 0.120 |
Why?
|
Environment | 1 | 2020 | 1124 | 0.120 |
Why?
|
Quinolines | 1 | 2019 | 730 | 0.120 |
Why?
|
Male | 29 | 2023 | 350027 | 0.120 |
Why?
|
Particulate Matter | 2 | 2022 | 2530 | 0.120 |
Why?
|
Psoriasis | 1 | 2021 | 898 | 0.110 |
Why?
|
Female | 28 | 2023 | 380197 | 0.110 |
Why?
|
Aorta | 1 | 2021 | 2061 | 0.110 |
Why?
|
Coronary Artery Bypass | 1 | 2022 | 2289 | 0.110 |
Why?
|
Aortic Valve | 1 | 2022 | 1921 | 0.100 |
Why?
|
Ventricular Remodeling | 1 | 2019 | 1224 | 0.100 |
Why?
|
Adipose Tissue | 1 | 2023 | 3278 | 0.100 |
Why?
|
HIV Infections | 3 | 2022 | 16718 | 0.090 |
Why?
|
Aged | 17 | 2023 | 163253 | 0.090 |
Why?
|
Death, Sudden, Cardiac | 1 | 2018 | 1541 | 0.090 |
Why?
|
Subtraction Technique | 1 | 2013 | 525 | 0.090 |
Why?
|
Head and Neck Neoplasms | 1 | 2023 | 2732 | 0.090 |
Why?
|
Perfusion | 1 | 2013 | 1359 | 0.080 |
Why?
|
Defibrillators, Implantable | 1 | 2018 | 1440 | 0.080 |
Why?
|
Stroke Volume | 5 | 2023 | 5008 | 0.080 |
Why?
|
Chronic Disease | 2 | 2020 | 9147 | 0.080 |
Why?
|
Obesity | 3 | 2023 | 12742 | 0.080 |
Why?
|
Brain Ischemia | 1 | 2022 | 3265 | 0.080 |
Why?
|
Coronary Disease | 2 | 2019 | 6078 | 0.080 |
Why?
|
Air Pollution | 1 | 2021 | 2286 | 0.070 |
Why?
|
Adult | 11 | 2021 | 214035 | 0.070 |
Why?
|
Anticoagulants | 1 | 2022 | 4599 | 0.070 |
Why?
|
Socioeconomic Factors | 1 | 2020 | 7784 | 0.070 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2024 | 4266 | 0.070 |
Why?
|
Prospective Studies | 5 | 2022 | 53280 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2019 | 2208 | 0.070 |
Why?
|
Body Water | 1 | 2006 | 343 | 0.060 |
Why?
|
Risk Assessment | 3 | 2021 | 23337 | 0.060 |
Why?
|
Expert Testimony | 1 | 2017 | 356 | 0.060 |
Why?
|
Adrenal Cortex Hormones | 1 | 2013 | 1854 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2020 | 3523 | 0.060 |
Why?
|
Prevalence | 1 | 2020 | 15226 | 0.060 |
Why?
|
Anti-HIV Agents | 1 | 2019 | 4256 | 0.060 |
Why?
|
Macrophages | 1 | 2018 | 5657 | 0.060 |
Why?
|
Sciatic Nerve | 1 | 2006 | 608 | 0.050 |
Why?
|
Myelin Sheath | 1 | 2006 | 655 | 0.050 |
Why?
|
Income | 2 | 2021 | 1913 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2018 | 19907 | 0.050 |
Why?
|
Documentation | 1 | 2017 | 869 | 0.050 |
Why?
|
Recurrence | 1 | 2013 | 8343 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14726 | 0.050 |
Why?
|
Periodontium | 1 | 2021 | 99 | 0.050 |
Why?
|
Leukopoiesis | 1 | 2020 | 56 | 0.050 |
Why?
|
C-Reactive Protein | 2 | 2024 | 3778 | 0.050 |
Why?
|
Infarction | 1 | 2022 | 246 | 0.050 |
Why?
|
Incidence | 1 | 2018 | 20945 | 0.050 |
Why?
|
Follow-Up Studies | 5 | 2019 | 39045 | 0.040 |
Why?
|
Crime | 1 | 2020 | 215 | 0.040 |
Why?
|
Whole Body Imaging | 1 | 2020 | 280 | 0.040 |
Why?
|
Noise | 1 | 2020 | 279 | 0.040 |
Why?
|
Oxidation-Reduction | 1 | 2023 | 2187 | 0.040 |
Why?
|
Consensus | 1 | 2017 | 2958 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2024 | 63119 | 0.040 |
Why?
|
Electrons | 1 | 2019 | 269 | 0.040 |
Why?
|
Cross-Sectional Studies | 1 | 2018 | 25043 | 0.040 |
Why?
|
Causality | 1 | 2023 | 1275 | 0.040 |
Why?
|
Ethanol | 1 | 2023 | 1342 | 0.040 |
Why?
|
Vasculitis | 1 | 2020 | 521 | 0.030 |
Why?
|
Spleen | 1 | 2021 | 2361 | 0.030 |
Why?
|
Societies, Medical | 1 | 2017 | 3741 | 0.030 |
Why?
|
Animals | 4 | 2023 | 168788 | 0.030 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2019 | 840 | 0.030 |
Why?
|
CD4 Lymphocyte Count | 1 | 2021 | 2559 | 0.030 |
Why?
|
Cohort Studies | 3 | 2023 | 40559 | 0.030 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2006 | 2737 | 0.030 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2017 | 3328 | 0.030 |
Why?
|
Troponin | 1 | 2018 | 524 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2019 | 1677 | 0.030 |
Why?
|
Exercise Test | 1 | 2021 | 2075 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2018 | 1200 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2022 | 1789 | 0.030 |
Why?
|
Primary Prevention | 1 | 2019 | 1167 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2021 | 3201 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2023 | 3966 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2019 | 1889 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2019 | 6893 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2023 | 11007 | 0.020 |
Why?
|
Arrhythmias, Cardiac | 1 | 2018 | 2267 | 0.020 |
Why?
|
Monocytes | 1 | 2018 | 2594 | 0.020 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2018 | 2072 | 0.020 |
Why?
|
Fibroblasts | 1 | 2018 | 4156 | 0.020 |
Why?
|
Homeostasis | 1 | 2018 | 3339 | 0.020 |
Why?
|
Survival Rate | 1 | 2019 | 12781 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2019 | 12035 | 0.020 |
Why?
|
Tachycardia, Ventricular | 1 | 2013 | 1273 | 0.020 |
Why?
|
Biopsy | 1 | 2016 | 6757 | 0.020 |
Why?
|
Survival Analysis | 1 | 2017 | 10250 | 0.020 |
Why?
|
Cytokines | 1 | 2019 | 7326 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2018 | 14556 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2018 | 57768 | 0.010 |
Why?
|
Xenopus laevis | 1 | 2006 | 957 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 9960 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2006 | 3509 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12244 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2018 | 21824 | 0.010 |
Why?
|
Aging | 1 | 2018 | 8661 | 0.010 |
Why?
|
Time Factors | 1 | 2020 | 40063 | 0.010 |
Why?
|
Hypertension | 1 | 2018 | 8480 | 0.010 |
Why?
|
United States | 1 | 2021 | 69867 | 0.010 |
Why?
|
Mice | 1 | 2018 | 81178 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 35423 | 0.010 |
Why?
|